drugset / Trial / NCT00205491

Pharmacological Intervention in Depression After Traumatic Brain Injury

NCT00205491

RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if treatment with venlafaxine reduces symptoms of depression in persons with traumatic brain injury.

Timeline

Start
2004-10
Primary completion
2007-09
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Venlafaxine Small molecule